EQUIDACENT Trademark

Trademark Overview

On Wednesday, September 26, 2018, a trademark application was filed for EQUIDACENT with the United States Patent and Trademark Office. The USPTO has given the EQUIDACENT trademark a serial number of 88132059. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 18, 2021. This trademark is owned by AstraZeneca AB. The EQUIDACENT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for use in oncology
equidacent

General Information

Serial Number88132059
Word MarkEQUIDACENT
Filing DateWednesday, September 26, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 18, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 23, 2019

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for use in oncology
Translation of Words in MarkThe wording "EQUIDACENT" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, October 3, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCENTUS BIOTHERAPEUTICS LIMITED
Party Type21 - New Owner After Publication
Legal Entity Type11 - Company
AddressCAMBRIDGE CB20AA
GB
Party NameAstraZeneca AB
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressSödertälje SE-15185
SE
Party NameAstraZeneca AB
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressSödertälje SE-15185
SE

Trademark Events

Event DateEvent Description
Monday, October 18, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, October 18, 2021ABANDONMENT - NO USE STATEMENT FILED
Thursday, July 22, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 22, 2021TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Thursday, July 22, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 22, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, March 19, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 18, 2021EXTENSION 3 GRANTED
Thursday, March 4, 2021EXTENSION 3 FILED
Wednesday, March 17, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, March 4, 2021TEAS EXTENSION RECEIVED
Wednesday, December 9, 2020AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, September 9, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 7, 2020EXTENSION 2 GRANTED
Monday, September 7, 2020EXTENSION 2 FILED
Monday, September 7, 2020TEAS EXTENSION RECEIVED
Wednesday, February 12, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 10, 2020EXTENSION 1 GRANTED
Monday, February 10, 2020EXTENSION 1 FILED
Monday, February 10, 2020TEAS EXTENSION RECEIVED
Tuesday, September 17, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, August 8, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, August 8, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, July 23, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 23, 2019PUBLISHED FOR OPPOSITION
Wednesday, July 3, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, June 14, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, June 13, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, June 13, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 11, 2019ASSIGNED TO LIE
Thursday, June 6, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, January 10, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, January 10, 2019NON-FINAL ACTION E-MAILED
Thursday, January 10, 2019NON-FINAL ACTION WRITTEN
Tuesday, January 8, 2019ASSIGNED TO EXAMINER
Wednesday, October 3, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, September 29, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

equidacent oncology substances preparations pharmaceutical